IDRSF
Price
$3.00
Change
-$0.01 (-0.33%)
Updated
Jul 18 closing price
Capitalization
745.41M
IVBXF
Price
$11.43
Change
-$0.04 (-0.35%)
Updated
Jul 18 closing price
Capitalization
19.39B
Interact to see
Advertisement

IDRSF vs IVBXF

Header iconIDRSF vs IVBXF Comparison
Open Charts IDRSF vs IVBXFBanner chart's image
Idorsia AG
Price$3.00
Change-$0.01 (-0.33%)
Volume$150
Capitalization745.41M
Innovent Biologics
Price$11.43
Change-$0.04 (-0.35%)
Volume$3.03K
Capitalization19.39B
IDRSF vs IVBXF Comparison Chart in %
Loading...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDRSF vs. IVBXF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDRSF is a Hold and IVBXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (IDRSF: $3.00 vs. IVBXF: $11.43)
Brand notoriety: IDRSF and IVBXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDRSF: 19% vs. IVBXF: 8%
Market capitalization -- IDRSF: $745.41M vs. IVBXF: $19.39B
IDRSF [@Biotechnology] is valued at $745.41M. IVBXF’s [@Biotechnology] market capitalization is $19.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDRSF’s FA Score shows that 0 FA rating(s) are green whileIVBXF’s FA Score has 0 green FA rating(s).

  • IDRSF’s FA Score: 0 green, 5 red.
  • IVBXF’s FA Score: 0 green, 5 red.
According to our system of comparison, IVBXF is a better buy in the long-term than IDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDRSF’s TA Score shows that 4 TA indicator(s) are bullish while IVBXF’s TA Score has 3 bullish TA indicator(s).

  • IDRSF’s TA Score: 4 bullish, 3 bearish.
  • IVBXF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IDRSF is a better buy in the short-term than IVBXF.

Price Growth

IDRSF (@Biotechnology) experienced а -0.50% price change this week, while IVBXF (@Biotechnology) price change was +12.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($19.4B) has a higher market cap than IDRSF($745M). IDRSF YTD gains are higher at: 252.941 vs. IVBXF (154.000).
IDRSFIVBXFIDRSF / IVBXF
Capitalization745M19.4B4%
EBITDA-189.01MN/A-
Gain YTD252.941154.000164%
P/E Ratio4.54N/A-
Revenue161MN/A-
Total Cash64.8MN/A-
Total Debt1.25BN/A-
FUNDAMENTALS RATINGS
IDRSF vs IVBXF: Fundamental Ratings
IDRSF
IVBXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10063
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
3435
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IVBXF's Valuation (65) in the null industry is in the same range as IDRSF (81). This means that IVBXF’s stock grew similarly to IDRSF’s over the last 12 months.

IVBXF's Profit vs Risk Rating (63) in the null industry is somewhat better than the same rating for IDRSF (100). This means that IVBXF’s stock grew somewhat faster than IDRSF’s over the last 12 months.

IVBXF's SMR Rating (96) in the null industry is in the same range as IDRSF (100). This means that IVBXF’s stock grew similarly to IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (34) in the null industry is in the same range as IVBXF (35). This means that IDRSF’s stock grew similarly to IVBXF’s over the last 12 months.

IDRSF's P/E Growth Rating (97) in the null industry is in the same range as IVBXF (100). This means that IDRSF’s stock grew similarly to IVBXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDRSFIVBXF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
62%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
62%
MACD
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 11 days ago
61%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 11 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POOL298.860.05
+0.02%
Pool Corp
PKST13.60N/A
N/A
Peakstone Realty Trust
AQB0.80N/A
-0.06%
AquaBounty Technologies
DXC14.39-0.17
-1.17%
DXC Technology Company
FNGR1.63-0.02
-1.21%
FingerMotion

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and CADL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
-0.33%
CADL - IDRSF
25%
Poorly correlated
-2.60%
NDTP - IDRSF
22%
Poorly correlated
N/A
ANNX - IDRSF
22%
Poorly correlated
-0.85%
HRTX - IDRSF
21%
Poorly correlated
-3.50%
LGVN - IDRSF
21%
Poorly correlated
-1.30%
More

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-0.35%
WXXWY - IVBXF
24%
Poorly correlated
+1.67%
BNTC - IVBXF
23%
Poorly correlated
-5.96%
MBXBF - IVBXF
7%
Poorly correlated
N/A
ISCO - IVBXF
5%
Poorly correlated
-23.74%
IDRSF - IVBXF
4%
Poorly correlated
-0.33%
More